Anthem (NYSE:ANTM – Get Rating) issued an update on its FY 2022 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $28.400-$ for the period, compared to the Thomson Reuters consensus earnings per share estimate of $28.480. The company issued revenue guidance of -.
Several research firms have recently commented on ANTM. UBS Group boosted their price target on shares of Anthem from $477.00 to $541.00 and gave the company a buy rating in a report on Tuesday, March 29th. Sanford C. Bernstein upped their target price on Anthem from $559.00 to $574.00 in a research report on Tuesday, January 11th. Jefferies Financial Group reiterated a buy rating and set a $559.00 price target on shares of Anthem in a report on Tuesday, March 29th. SVB Leerink increased their price objective on Anthem from $465.00 to $483.00 and gave the stock a market perform rating in a report on Tuesday, March 15th. Finally, Morgan Stanley reduced their target price on shares of Anthem from $561.00 to $518.00 and set an overweight rating for the company in a research note on Friday, January 28th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of Buy and an average target price of $494.43.
Shares of ANTM stock opened at $517.04 on Wednesday. The stock has a 50 day moving average of $475.94 and a 200-day moving average of $445.93. The firm has a market cap of $130.95 billion, a PE ratio of 20.92, a price-to-earnings-growth ratio of 1.46 and a beta of 1.05. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.59. Anthem has a 12 month low of $355.43 and a 12 month high of $526.62.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 24th. Investors of record on Friday, June 10th will be paid a dividend of $1.28 per share. This represents a $5.12 annualized dividend and a yield of 0.99%. This is a positive change from Anthem’s previous quarterly dividend of $1.13. Anthem’s payout ratio is currently 20.71%.
In other news, CAO Ronald W. Penczek sold 2,423 shares of the stock in a transaction that occurred on Thursday, March 3rd. The shares were sold at an average price of $463.68, for a total transaction of $1,123,496.64. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Peter D. Haytaian sold 17,703 shares of the business’s stock in a transaction that occurred on Thursday, March 10th. The stock was sold at an average price of $460.71, for a total transaction of $8,155,949.13. The disclosure for this sale can be found here. Insiders have sold a total of 22,889 shares of company stock valued at $10,532,411 over the last ninety days. 0.27% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC bought a new stake in shares of Anthem during the fourth quarter worth $255,000. NEXT Financial Group Inc raised its holdings in Anthem by 17.1% during the 4th quarter. NEXT Financial Group Inc now owns 554 shares of the company’s stock worth $257,000 after purchasing an additional 81 shares during the last quarter. Autumn Glory Partners LLC acquired a new position in Anthem during the 4th quarter valued at about $268,000. Kingsview Wealth Management LLC lifted its position in Anthem by 4.8% during the 4th quarter. Kingsview Wealth Management LLC now owns 1,095 shares of the company’s stock valued at $508,000 after purchasing an additional 50 shares during the period. Finally, Penserra Capital Management LLC boosted its stake in shares of Anthem by 20.4% in the 4th quarter. Penserra Capital Management LLC now owns 1,159 shares of the company’s stock valued at $536,000 after purchasing an additional 196 shares during the last quarter. 87.97% of the stock is owned by institutional investors.
About Anthem (Get Rating)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
- Get a free copy of the StockNews.com research report on Anthem (ANTM)
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
- Constellation Brands Stock is Launching Towards New Highs
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.